🕵️ Bioforce Nanosciences Holdings, Inc. ($BFNH)
SEC insider & ownership activity, last 12 months · CIK 1310488 · every row links its SEC filing
Over the last 12 months insiders sold $400K with no open-market buying against it. Ferguson Merle sold $400K in discretionary trades (Apr). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 1 seller, $400K (1 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Ferguson Merle | 0 | – | 1 | $400K | Apr 22, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Nexus Capital Investments, Inc. | 79.6% | 13D | Apr 22, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Unregistered equity sale (3.02) | Aug 31, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 17, 2026 | filing ↗ |
| Other events (8.01) | Aug 14, 2026 | filing ↗ |
| Other events (8.01) | Jul 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 1, 2026 | filing ↗ |
| Other events (8.01) | Jun 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 5, 2026 | filing ↗ |
| Change of control (5.01) | Apr 15, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 15, 2026 | filing ↗ |
| Other events (8.01) | Apr 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 15, 2026 | filing ↗ |